title: Editorial: Closing in on the Role of Thymic Stromal Lymphopoietin Inhibition as a Therapeutic Entry Point for Systemic Sclerosis.
authors.affiliation: University Medical Center Utrecht, Utrecht, The Netherlands.
authors.forename: Alsya J
authors.initials: AJ
authors.lastname: Affandi
authors.affiliation: University Medical Center Utrecht, Utrecht, The Netherlands. j.vanroon@umcutrecht.nl.
authors.forename: Joel A G
authors.initials: JA
authors.lastname: van Roon
mesh_terms: D016207:Cytokines; D006801:Humans; D018121:Receptors, Cytokine; D012595:Scleroderma, Systemic; D000094632:Thymic Stromal Lymphopoietin
chemical_list: D016207:Cytokines; D018121:Receptors, Cytokine; D000094632:Thymic Stromal Lymphopoietin